227 related articles for article (PubMed ID: 12558666)
1. Prevalence of family history of breast and ovarian cancer in a single primary care practice using a self-administered questionnaire.
Hughes KS; Roche C; Campbell CT; Siegel N; Salisbury L; Chekos A; Katz MS; Edell E
Breast J; 2003; 9(1):19-25. PubMed ID: 12558666
[TBL] [Abstract][Full Text] [Related]
2. The prevalence of hereditary breast/ovarian cancer risk in patients with a history of breast or ovarian cancer in Japanese subjects.
Komata D; Yahata T; Kodama S; Koyama Y; Takeda N; Tajima K; Makino H; Sato N; Muto I; Hatakeyama K; Tanaka K
J Obstet Gynaecol Res; 2009 Oct; 35(5):912-7. PubMed ID: 20149041
[TBL] [Abstract][Full Text] [Related]
3. Identification of hereditary cancer in the general population: development and validation of a screening questionnaire for obtaining the family history of cancer.
Campacci N; de Lima JO; Carvalho AL; Michelli RD; Haikel R; Mauad E; Viana DV; Melendez ME; Vazquez FL; Zanardo C; Reis RM; Rossi BM; Palmero EI
Cancer Med; 2017 Dec; 6(12):3014-3024. PubMed ID: 29055968
[TBL] [Abstract][Full Text] [Related]
4. Hereditary susceptibility to breast cancer: significance of age of onset in family history and contribution of BRCA1 and BRCA2.
Frank TS; Deffenbaugh AM; Hulick M; Gumpper K
Dis Markers; 1999 Oct; 15(1-3):89-92. PubMed ID: 10595259
[TBL] [Abstract][Full Text] [Related]
5. Cancer screening and risk-reducing behaviors of women seeking genetic cancer risk assessment for breast and ovarian cancers.
MacDonald DJ; Sarna L; Uman GC; Grant M; Weitzel JN
Oncol Nurs Forum; 2006 Nov; 33(2):E27-35. PubMed ID: 16518435
[TBL] [Abstract][Full Text] [Related]
6. Family history of breast and ovarian cancers and BRCA1 and BRCA2 mutations in a population-based series of early-onset breast cancer.
Loman N; Johannsson O; Kristoffersson U; Olsson H; Borg A
J Natl Cancer Inst; 2001 Aug; 93(16):1215-23. PubMed ID: 11504767
[TBL] [Abstract][Full Text] [Related]
7. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
8. Population prevalence of first- and second-degree family history of breast and ovarian cancer.
Moghimi-Dehkordi B; Safaee A; Vahedi M; Pourhoseingholi MA; Pourhoseingholi A; Zali MR
East Afr J Public Health; 2011 Dec; 8(4):275-7. PubMed ID: 23120936
[TBL] [Abstract][Full Text] [Related]
9. Factors associated with the incompliance with mammogram screening among individuals with a family history of breast cancer or ovarian cancer.
Wu H; Zhu K; Jatoi I; Shah M; Shriver CD; Potter J
Breast Cancer Res Treat; 2007 Mar; 101(3):317-24. PubMed ID: 16821080
[TBL] [Abstract][Full Text] [Related]
10. Population prevalence of familial cancer and common hereditary cancer syndromes. The 2005 California Health Interview Survey.
Scheuner MT; McNeel TS; Freedman AN
Genet Med; 2010 Nov; 12(11):726-35. PubMed ID: 20921897
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of hereditary breast/ovarian carcinoma risk in patients with a personal history of breast or ovarian carcinoma in a mammography population.
Dominguez FJ; Jones JL; Zabicki K; Smith BL; Gadd MA; Specht M; Kopans DB; Moore RH; Michaelson JS; Hughes KS
Cancer; 2005 Nov; 104(9):1849-53. PubMed ID: 16136597
[TBL] [Abstract][Full Text] [Related]
12. A cross-sectional survey to estimate the prevalence of family history of colorectal, breast and ovarian cancer in a Scottish general practice population.
Wallace E; Hinds A; Campbell H; Mackay J; Cetnarskyj R; Porteous ME
Br J Cancer; 2004 Oct; 91(8):1575-9. PubMed ID: 15381929
[TBL] [Abstract][Full Text] [Related]
13. Set-up of a population-based familial breast cancer registry in Geneva, Switzerland: validation of first results.
Verkooijen HM; Fioretta G; Chappuis PO; Vlastos G; Sappino AP; Benhamou S; Bouchardy C
Ann Oncol; 2004 Feb; 15(2):350-3. PubMed ID: 14760133
[TBL] [Abstract][Full Text] [Related]
14. Familial breast cancer in southern Finland: how prevalent are breast cancer families and can we trust the family history reported by patients?
Eerola H; Blomqvist C; Pukkala E; Pyrhönen S; Nevanlinna H
Eur J Cancer; 2000 Jun; 36(9):1143-8. PubMed ID: 10854948
[TBL] [Abstract][Full Text] [Related]
15. Aggregation of ovarian cancer with breast, ovarian, colorectal, and prostate cancer in first-degree relatives.
Tung KH; Goodman MT; Wu AH; McDuffie K; Wilkens LR; Nomura AM; Kolonel LN
Am J Epidemiol; 2004 Apr; 159(8):750-8. PubMed ID: 15051584
[TBL] [Abstract][Full Text] [Related]
16. Association of parity and ovarian cancer risk by family history of breast or ovarian cancer in a population-based study of postmenopausal women.
Vachon CM; Mink PJ; Janney CA; Sellers TA; Cerhan JR; Hartmann L; Folsom AR
Epidemiology; 2002 Jan; 13(1):66-71. PubMed ID: 11805588
[TBL] [Abstract][Full Text] [Related]
17. Screening of over 1000 Indian patients with breast and/or ovarian cancer with a multi-gene panel: prevalence of BRCA1/2 and non-BRCA mutations.
Singh J; Thota N; Singh S; Padhi S; Mohan P; Deshwal S; Sur S; Ghosh M; Agarwal A; Sarin R; Ahmed R; Almel S; Chakraborti B; Raina V; DadiReddy PK; Smruti BK; Rajappa S; Dodagoudar C; Aggarwal S; Singhal M; Joshi A; Kumar R; Kumar A; Mishra DK; Arora N; Karaba A; Sankaran S; Katragadda S; Ghosh A; Veeramachaneni V; Hariharan R; Mannan AU
Breast Cancer Res Treat; 2018 Jul; 170(1):189-196. PubMed ID: 29470806
[TBL] [Abstract][Full Text] [Related]
18. Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment.
Desmond A; Kurian AW; Gabree M; Mills MA; Anderson MJ; Kobayashi Y; Horick N; Yang S; Shannon KM; Tung N; Ford JM; Lincoln SE; Ellisen LW
JAMA Oncol; 2015 Oct; 1(7):943-51. PubMed ID: 26270727
[TBL] [Abstract][Full Text] [Related]
19. National Estimates of Genetic Testing in Women With a History of Breast or Ovarian Cancer.
Childers CP; Childers KK; Maggard-Gibbons M; Macinko J
J Clin Oncol; 2017 Dec; 35(34):3800-3806. PubMed ID: 28820644
[TBL] [Abstract][Full Text] [Related]
20. Ovarian and breast cancer risks to women in families with two or more cases of ovarian cancer.
Sutcliffe S; Pharoah PD; Easton DF; Ponder BA
Int J Cancer; 2000 Jul; 87(1):110-7. PubMed ID: 10861460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
